Maranguape, Nova Lima Begin Dengue Vaccination as Brazil Pilots Single-Dose Butantan Shot

Overview

• Maranguape (CE) and Nova Lima (MG) start vaccinations on Saturday, with Botucatu (SP) launching a mass campaign on Sunday as part of a coordinated study.
• The Butantan-DV vaccine, approved by Anvisa, is the world’s first single-dose dengue shot and uses a live-attenuated virus platform.
• Trials with more than 16,000 volunteers showed nearly 75% protection against symptomatic dengue, over 91% against severe disease, and 100% against hospitalizations.
• Campaigns prioritize people aged 15 to 59 for Butantan-DV, while Maranguape also offers Takeda’s two-dose vaccine to those aged 10 to 14.
• Operations include Day D events, drive-thru and mobile units, vaccination at UBS sites, free access via SUS, and required documentation such as photo ID, CPF, SUS card, and proof of residence.